- Home
- SEER vs OFS Comparison
SEER vs OFS Comparison
Compare SEER & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- OFS
- Stock Information
- Founded
- SEER 2017
- OFS 2001
- Country
- SEER United States
- OFS United States
- Employees
- SEER 134
- OFS N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- OFS Finance/Investors Services
- Sector
- SEER Health Care
- OFS Finance
- Exchange
- SEER Nasdaq
- OFS Nasdaq
- Market Cap
- SEER 121.8M
- OFS 110.3M
- IPO Year
- SEER 2020
- OFS 2012
- Fundamental
- Price
- SEER $1.84
- OFS $8.49
- Analyst Decision
- SEER Hold
- OFS
- Analyst Count
- SEER 1
- OFS 0
- Target Price
- SEER $3.00
- OFS N/A
- AVG Volume (30 Days)
- SEER 174.6K
- OFS 42.9K
- Earning Date
- SEER 05-13-2025
- OFS 05-01-2025
- Dividend Yield
- SEER N/A
- OFS 16.00%
- EPS Growth
- SEER N/A
- OFS N/A
- EPS
- SEER N/A
- OFS 2.25
- Revenue
- SEER $14,170,000.00
- OFS $44,026,000.00
- Revenue This Year
- SEER $23.54
- OFS N/A
- Revenue Next Year
- SEER $42.98
- OFS N/A
- P/E Ratio
- SEER N/A
- OFS $3.77
- Revenue Growth
- SEER N/A
- OFS N/A
- 52 Week Low
- SEER $1.56
- OFS $7.75
- 52 Week High
- SEER $2.63
- OFS $10.04
- Technical
- Relative Strength Index (RSI)
- SEER 41.77
- OFS 45.57
- Support Level
- SEER $1.88
- OFS $8.68
- Resistance Level
- SEER $1.97
- OFS $8.92
- Average True Range (ATR)
- SEER 0.10
- OFS 0.32
- MACD
- SEER -0.02
- OFS -0.01
- Stochastic Oscillator
- SEER 0.00
- OFS 14.95
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.